US Stock MarketDetailed Quotes

CATX Perspective Therapeutics

Watchlist

1.3600
+0.0400+3.03%

Trading May 31 11:27 ET

916.84MMarket Cap-7234P/E (TTM)

Perspective Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Jun 30, 2022

(Q3)Mar 31, 2022

(Q2)Dec 31, 2021

Total revenue

-309.14%-5.24M

-34.40%1.91M

1.5M

-64.67%3.55M

-7.56%2.51M

11.92%2.91M

19.37%2.82M

Operating revenue

--0

-309.14%-5.24M

-34.40%1.91M

--1.5M

--0

-64.67%3.55M

-7.56%2.51M

11.92%2.91M

19.37%2.82M

Cost of revenue

-1.50%1.45M

1.84M

-44.55%2.74M

15.76%1.58M

18.66%1.47M

33.89%1.6M

Gross profit

-48.79%738K

248K

-84.05%817K

-31.20%926K

5.80%1.44M

4.54%1.22M

Operating expense

33.54%13.01M

386.93%40.94M

145.78%7.45M

290.34%11M

11.03M

9.74M

-1.75%8.41M

24.31%3.03M

32.50%2.82M

40.43%2.86M

Selling and administrative expenses

-11.78%5.88M

196.38%21.06M

-24.24%1.69M

144.75%5.55M

--5.98M

--6.66M

-0.34%7.11M

13.44%2.24M

28.57%2.27M

32.72%2.32M

-Selling and marketing expense

----

24.45%855K

--911K

----

-34.46%1.57M

-0.49%607K

18.24%687K

13.41%702K

-General and administrative expense

-11.78%5.88M

280.22%21.06M

162.25%4.27M

197.03%4.7M

--5.07M

--6.66M

16.88%5.54M

19.69%1.63M

33.64%1.58M

43.31%1.62M

Research and development costs

125.20%7.45M

1,538.05%21.31M

663.82%6.08M

942.08%5.72M

--5.65M

--3.31M

-8.83%1.3M

70.09%796K

51.66%549K

87.72%535K

Other operating expenses

-39.48%-325K

---1.43M

---322K

---276K

---603K

---233K

----

Operating profit

-33.54%-13.01M

-439.34%-40.94M

-323.79%-8.93M

-645.49%-10.26M

-10.79M

-9.74M

-120.86%-7.59M

-92.68%-2.11M

-80.10%-1.38M

-88.80%-1.64M

Net non-operating interest income expense

232.02%1.18M

51.52%850K

35.71%38K

555.17%190K

266K

356K

850.85%561K

-12.50%28K

38.10%29K

520.00%31K

Non-operating interest income

223.80%1.21M

66.49%934K

121.43%62K

603.45%204K

--294K

--374K

850.85%561K

-12.50%28K

38.10%29K

520.00%31K

Non-operating interest expense

61.11%29K

--84K

--24K

--14K

--28K

--18K

----

Other net income (expense)

90.91%-2K

95.08%-15K

17K

-12K

-22K

-3,288.89%-305K

Earnings from equity interest

---2K

---17K

---5K

---12K

----

--0

----

Special income (charges)

--0

--22K

--0

---22K

-3,288.89%-305K

--0

-Gain on sale of property,plant,equipment

--0

--22K

--0

---22K

-3,288.89%-305K

--0

Other non- operating income (expenses)

----

--2K

--0

----

--2K

----

Income before tax

-25.73%-11.83M

-446.78%-40.11M

-326.85%-8.87M

-648.33%-10.08M

-10.52M

-9.41M

-116.56%-7.34M

-95.85%-2.08M

-80.81%-1.35M

-84.79%-1.6M

Income tax

-2.65M

7.85M

-10.5M

Net income

-3,211.05%-12.28M

-534.06%-46.51M

-1,140.23%-25.77M

-648.33%-10.08M

-10.52M

-371K

-116.56%-7.34M

-95.85%-2.08M

-80.81%-1.35M

-84.79%-1.6M

Net income continuous Operations

-1,179.91%-11.83M

-410.63%-37.46M

-704.57%-16.72M

-648.33%-10.08M

---10.52M

--1.1M

-116.56%-7.34M

-95.85%-2.08M

-80.81%-1.35M

-84.79%-1.6M

Net income discontinuous operations

68.55%-461K

---9.05M

----

---1.47M

----

Net income extraordinary

--2K

----

--0

----

Minority interest income

Net income attributable to the parent company

-3,211.05%-12.28M

-534.06%-46.51M

-1,087.44%-24.68M

-668.82%-10.36M

-11.11M

-371K

-116.56%-7.34M

-95.85%-2.08M

-80.81%-1.35M

-84.79%-1.6M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-3,211.05%-12.28M

-534.06%-46.51M

-1,087.44%-24.68M

-668.82%-10.36M

-11.11M

-371K

-116.37%-7.34M

-95.85%-2.08M

-80.81%-1.35M

-84.79%-1.6M

Basic earnings per share

-0.02

-240.00%-0.17

-800.00%-0.09

-300.00%-0.04

-0.04

-66.67%-0.05

0.00%-0.01

Diluted earnings per share

-0.02

-240.00%-0.17

-800.00%-0.09

-300.00%-0.04

-0.04

-66.67%-0.05

0.00%-0.01

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Jun 30, 2022	(Q3)Mar 31, 2022	(Q2)Dec 31, 2021
Total revenue	0	0	-309.14%-5.24M	-34.40%1.91M	1.5M	0	-64.67%3.55M	-7.56%2.51M	11.92%2.91M	19.37%2.82M
Operating revenue	--0	--0	-309.14%-5.24M	-34.40%1.91M	--1.5M	--0	-64.67%3.55M	-7.56%2.51M	11.92%2.91M	19.37%2.82M
Cost of revenue				-1.50%1.45M	1.84M		-44.55%2.74M	15.76%1.58M	18.66%1.47M	33.89%1.6M
Gross profit				-48.79%738K	248K		-84.05%817K	-31.20%926K	5.80%1.44M	4.54%1.22M
Operating expense	33.54%13.01M	386.93%40.94M	145.78%7.45M	290.34%11M	11.03M	9.74M	-1.75%8.41M	24.31%3.03M	32.50%2.82M	40.43%2.86M
Selling and administrative expenses	-11.78%5.88M	196.38%21.06M	-24.24%1.69M	144.75%5.55M	--5.98M	--6.66M	-0.34%7.11M	13.44%2.24M	28.57%2.27M	32.72%2.32M
-Selling and marketing expense	----	----	----	24.45%855K	--911K	----	-34.46%1.57M	-0.49%607K	18.24%687K	13.41%702K
-General and administrative expense	-11.78%5.88M	280.22%21.06M	162.25%4.27M	197.03%4.7M	--5.07M	--6.66M	16.88%5.54M	19.69%1.63M	33.64%1.58M	43.31%1.62M
Research and development costs	125.20%7.45M	1,538.05%21.31M	663.82%6.08M	942.08%5.72M	--5.65M	--3.31M	-8.83%1.3M	70.09%796K	51.66%549K	87.72%535K
Other operating expenses	-39.48%-325K	---1.43M	---322K	---276K	---603K	---233K	----	----	----	----
Operating profit	-33.54%-13.01M	-439.34%-40.94M	-323.79%-8.93M	-645.49%-10.26M	-10.79M	-9.74M	-120.86%-7.59M	-92.68%-2.11M	-80.10%-1.38M	-88.80%-1.64M
Net non-operating interest income expense	232.02%1.18M	51.52%850K	35.71%38K	555.17%190K	266K	356K	850.85%561K	-12.50%28K	38.10%29K	520.00%31K
Non-operating interest income	223.80%1.21M	66.49%934K	121.43%62K	603.45%204K	--294K	--374K	850.85%561K	-12.50%28K	38.10%29K	520.00%31K
Non-operating interest expense	61.11%29K	--84K	--24K	--14K	--28K	--18K	----	----	----	----
Other net income (expense)	90.91%-2K	95.08%-15K	17K	-12K	2K	-22K	-3,288.89%-305K
Earnings from equity interest	---2K	---17K	---5K	---12K	----	--0	----	----	----	----
Special income (charges)	--0	--0	--22K	--0	--0	---22K	-3,288.89%-305K	--0	--0	--0
-Gain on sale of property,plant,equipment	--0	--0	--22K	--0	--0	---22K	-3,288.89%-305K	--0	--0	--0
Other non- operating income (expenses)	----	--2K	--0	----	--2K	----	----	----	----	----
Income before tax	-25.73%-11.83M	-446.78%-40.11M	-326.85%-8.87M	-648.33%-10.08M	-10.52M	-9.41M	-116.56%-7.34M	-95.85%-2.08M	-80.81%-1.35M	-84.79%-1.6M
Income tax	0	-2.65M	7.85M	0	0	-10.5M
Net income	-3,211.05%-12.28M	-534.06%-46.51M	-1,140.23%-25.77M	-648.33%-10.08M	-10.52M	-371K	-116.56%-7.34M	-95.85%-2.08M	-80.81%-1.35M	-84.79%-1.6M
Net income continuous Operations	-1,179.91%-11.83M	-410.63%-37.46M	-704.57%-16.72M	-648.33%-10.08M	---10.52M	--1.1M	-116.56%-7.34M	-95.85%-2.08M	-80.81%-1.35M	-84.79%-1.6M
Net income discontinuous operations	68.55%-461K	---9.05M	----	----	----	---1.47M	----	----	----	----
Net income extraordinary	--2K	----	----	----	----	--0	----	----	----	----
Minority interest income
Net income attributable to the parent company	-3,211.05%-12.28M	-534.06%-46.51M	-1,087.44%-24.68M	-668.82%-10.36M	-11.11M	-371K	-116.56%-7.34M	-95.85%-2.08M	-80.81%-1.35M	-84.79%-1.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-3,211.05%-12.28M	-534.06%-46.51M	-1,087.44%-24.68M	-668.82%-10.36M	-11.11M	-371K	-116.37%-7.34M	-95.85%-2.08M	-80.81%-1.35M	-84.79%-1.6M
Basic earnings per share	-0.02	-240.00%-0.17	-800.00%-0.09	-300.00%-0.04	-0.04	0	-66.67%-0.05	0.00%-0.01	0.00%-0.01	0.00%-0.01
Diluted earnings per share	-0.02	-240.00%-0.17	-800.00%-0.09	-300.00%-0.04	-0.04	0	-66.67%-0.05	0.00%-0.01	0.00%-0.01	0.00%-0.01
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall